[HTML][HTML] Reactogenicity and safety of second trimester maternal tetanus, diphtheria and acellular pertussis vaccination in the Netherlands

MM Immink, JM Kemmeren, L Broeders, MN Bekker… - Vaccine, 2023 - Elsevier
Background Maternal tetanus-diphtheria-and-acellular-pertussis (Tdap) vaccination is
offered to all pregnant women during their second trimester in the Netherlands since …

[PDF][PDF] Reactogenicity and safety of second trimester maternal tetanus, diphtheria and acellular pertussis vaccination in the Netherlands

MM Immink, JM Kemmeren, L Broeders… - …, 2023 - researchinformation.umcutrecht.nl
abstract Background: Maternal tetanus-diphtheria-and-acellular-pertussis (Tdap)
vaccination is offered to all pregnant women during their second trimester in the Netherlands …

Reactogenicity and safety of second trimester maternal tetanus, diphtheria and acellular pertussis vaccination in the Netherlands

MM Immink, JM Kemmeren, L Broeders… - …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Maternal tetanus-diphtheria-and-acellular-pertussis (Tdap) vaccination is
offered to all pregnant women during their second trimester in the Netherlands since …

Reactogenicity and safety of second trimester maternal tetanus, diphtheria and acellular pertussis vaccination in the Netherlands.

MM Immink, JM Kemmeren, L Broeders, MN Bekker… - Vaccine, 2023 - europepmc.org
Background Maternal tetanus-diphtheria-and-acellular-pertussis (Tdap) vaccination is
offered to all pregnant women during their second trimester in the Netherlands since …

Reactogenicity and safety of second trimester maternal tetanus, diphtheria and acellular pertussis vaccination in the Netherlands.

MM Immink, JM Kemmeren, L Broeders, MN Bekker… - 2023 - cabidigitallibrary.org
Background: Maternal tetanus-diphtheria-and-acellular-pertussis (Tdap) vaccination is
offered to all pregnant women during their second trimester in the Netherlands since …